Form 4: Medpace Director Robert O. Kraft Receives Stock Options

Director Robert O. Kraft was granted 1,110 stock options in Medpace Holdings, Inc. as part of standard equity compensation.

Summary

• Director Robert O. Kraft received a grant of 1,110 stock options for Medpace Holdings, Inc. common stock.
• The options have an exercise price of $415.27 per share.
• The grant date is May 15, 2026, with an expiration date of May 15, 2033.
• The options vest on the earlier of the day before the next annual meeting or the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative disclosure regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Equity-based compensation aligns the interests of the director with those of shareholders.

Negatives

• None identified.

Risks

• Vesting is subject to continued service on the board of directors.

Future Outlook

The options vest on the earlier of the day preceding the first annual meeting following the grant or the first anniversary of the grant, contingent upon continued board service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the clinical research organization (CRO) sector to ensure long-term alignment with shareholder value.

Comparison to Industry Standards

• The grant of stock options to directors is consistent with standard compensation practices for publicly traded companies in the healthcare and life sciences sector.
• The vesting schedule is typical for annual director equity awards.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation event.

Next Steps

• Vesting of options on or before May 15, 2027.

Key Dates

Keywords

Medpace, MEDP, Form 4, Director Compensation, Stock Options, Insider Transaction